Schonfeld Strategic Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,900
| Closed | -$158K | – | 2214 |
|
|
2022
Q4 | $158K | Sell |
14,900
-111,800
| -88% | -$1.19M | ﹤0.01% | 2028 |
|
|
2022
Q3 | $1.23M | Buy |
126,700
+40,900
| +48% | +$397K | 0.01% | 1127 |
|
|
2022
Q2 | $1.24M | Buy |
85,800
+40,700
| +90% | +$590K | 0.01% | 857 |
|
|
2022
Q1 | $1.18M | Buy |
45,100
+26,400
| +141% | +$690K | 0.01% | 859 |
|
|
2021
Q4 | $740K | Buy |
18,700
+200
| +1% | +$7.91K | 0.01% | 1016 |
|
|
2021
Q3 | $925K | Buy |
18,500
+613
| +3% | +$30.7K | 0.01% | 922 |
|
|
2021
Q2 | $993K | Buy |
17,887
+1,587
| +10% | +$88.1K | 0.01% | 899 |
|
|
2021
Q1 | $762K | Buy |
16,300
+3,400
| +26% | +$159K | 0.01% | 952 |
|
|
2020
Q4 | $561K | Buy |
+12,900
| New | +$561K | 0.01% | 970 |
|